FRESOFOL 1%50ML MCT /LCT
July 10, 2020HEPARIN 500 IU
July 10, 2020
Heparin inhibits the clotting of blood and the formation of fibrin clots both in vitro and in vivo. In combination with a co-factor, it inactivates thrombin thus preventing the conversion of fibrinogen to fibrin. Heparin also prevents the formation of a stable fibrin clot by inhibiting the activation of the fibrin stabilizing factor.
Heparin Sodium inhibits reactions that lead to clotting but does not alter the normal components of the blood. Although clotting time is prolonged by therapeutic doses, bleeding time is usually unaffected. Heparin Sodium does not have fibrinolytic activity, therefore it will not lyse existing clots.